Zapping nerves to ease hip pain: new trial underway
NCT ID NCT07190339
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a procedure called pulsed radiofrequency can reduce chronic hip pain from osteoarthritis. The treatment uses ultrasound to guide a needle near nerves in the hip and delivers short electrical pulses. Researchers will track pain levels and hip function in 40 adults over 12 weeks to see if it provides lasting relief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pulsed radiofrequency treatment
- What this could lead to
- If it works, this could offer a non-surgical option for long-lasting hip pain relief without daily medication.
- What could go wrong
- This is a small, early-stage study with only 40 participants. The pain relief may be temporary or no better than existing treatments. There are also risks from the procedure itself, such as infection or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1\. Patients with hip and groin pain who have been diagnosed with hip osteoarthritis by direct radiography * 2\. Patients who have had hip pain above VAS 5 for more than 6 weeks * 3\. Failure of pain treatment with conservative methods such as analgesics and physical therapy Exclusion Criteria: * 1\. Patients with lumbar radiculopathy and axial back pain, sacroiliac joint, connective tissue disease * 2\. Patients who do not attend follow-up appointments regularly or cannot be reached by phone * 3\. Patients who started additional analgesic medication or underwent additional interventional procedures after the initial interventional procedure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hip ostearthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ankara Etlik City Hospital
RECRUITINGAnkara, Turkey (Türkiye)